Allarity Therapeutics, Inc. Amortization of Debt Issuance Costs and Discounts
Allarity Therapeutics, Inc. (ALLR) reported Amortization of Debt Issuance Costs and Discounts of $1.35 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2023-03-13
- Allarity Therapeutics, Inc. amortization of debt issuance costs and discounts for the quarter ending 2021-12-31 was $954.00K.
- Allarity Therapeutics, Inc. amortization of debt issuance costs and discounts for fiscal 2021 was $1.35M.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|
| 2021-12-31 | $954.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-13 | $1.35M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $393.00K 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |